MedPath

Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID

Not Applicable
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Other: control group
Behavioral: exercise group
Registration Number
NCT04639349
Lead Sponsor
Cairo University
Brief Summary

exercise activity during the COVID pandemic is appreciated to be conducted in home especially for chronic chest diseases as chronic obstructive pulmonary disease (COPD) to reduce the chance of viral contamination during the COVID-19 pandemic.

Detailed Description

40 COPD men will be divided to exercise group (20 patients) and control group (20 patients):

the exercise group will receive a exercise session contains a fifty minutes exercise training at home with moderate intensity on the available training devices as bicycle or treadmill in addition to 30 minutes of exercising of upper and lower limb, the session will be repeated three times per week for eight weeks.

The control group will not be trained

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
40
Inclusion Criteria
  • stable COPD patients
  • patients who will have a training device as bicycle or treadmill in home
Exclusion Criteria
  • diabetic patients
  • renal patients.
  • liver diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
control groupcontrol groupThe control group will not be trained
Exercised groupexercise groupthe exercise group (20 patients) will receive a exercise session contains a fifty minutes exercise training at home with moderate intensity on the available training devices as bicycle or treadmill in addition to 30 minutes of exercising of upper and lower limb, the session will be repeated three times per week for eight weeks.
Primary Outcome Measures
NameTimeMethod
hospital anxiety and depression scaleIt will be measured after eight weeks of training

this a questionnaire that will assess anxiety and depression in COPD patients

cortisolIt will be measured after eight weeks of training

it will be measured in plasma

Secondary Outcome Measures
NameTimeMethod
Interleukin-8It will be measured after eight weeks of training

It is an inflammatory marker in plasma

pulmonary function testIt will be measured after eight weeks of training

it will be a measurement for lung volume and capacities

body mass indexIt will be measured after eight weeks of training

it will measure body mass changes

six minute walking testIt will be measured after eight weeks of training

it assess functional capacity

St. George's respiratory questionnaireIt will be measured after eight weeks of training

It assess the effect of COPD on general quality of life

Trial Locations

Locations (1)

Faculty of Physical Therapy Cairo University

🇪🇬

Giza, Dokki, Egypt

© Copyright 2025. All Rights Reserved by MedPath